Succinate Dehydrogenase Gene Mutations in Cardiac Paragangliomas

Victoria L. Martucci, Abbas Emaminia, Jaydira Del Rivero, Ronald M. Lechan, Bindiya T. Magoon, Analyza Galia, Tito Fojo, Steve Leung, Roberto Lorusso, Camilo Jimenez, Barry L. Shulkin, Jennifer L. Audibert, Karen T. Adams, Douglas R. Rosing, Anand Vaidya, Robert G. Dluhy, Keith A. Horvath, Karel Pacak

Research output: Contribution to journalArticle

Abstract

Pheochromocytomas and paragangliomas are chromaffin cell tumors arising from neuroendocrine cells. At least 1/3 of paragangliomas are related to germline mutations in 1 of 17 genes. Although these tumors can occur throughout the body, cardiac paragangliomas are very rare, accounting for <0.3% of mediastinal tumors. The purpose of this study was to determine the clinical characteristics of patients with cardiac paragangliomas, particularly focusing on their genetic backgrounds. A retrospective chart analysis of 15 patients with cardiac paragangliomas was performed to determine clinical presentation, genetic background, diagnostic workup, and outcomes. The average age at diagnosis was 41.9 years. Typical symptoms of paraganglioma (e.g., hypertension, sweating, palpitations, headache) were reported at initial presentation in 13 patients (86.7%); the remaining 2, as well as 4 symptomatic patients, initially presented with cardiac-specific symptoms (e.g., chest pain, dyspnea). Genetic testing was done in 13 patients (86.7%); 10 (76.9%) were positive for mutations in succinate dehydrogenase (SDHx) subunits B, C, or D. Thirteen patients (86.7%) underwent surgery to remove the paraganglioma with no intraoperative morbidity or mortality; 1 additional patient underwent surgical resection but experienced intraoperative complications after removal of the tumor due to co-morbidities and did not survive. SDHx mutations are known to be associated with mediastinal locations and malignant behavior of paragangliomas. In this report, the investigators extend the locations of predominantly SDHx-related paragangliomas to cardiac tumors. In conclusion, cardiac paragangliomas are frequently associated with underlying SDHx germline mutations, suggesting a need for genetic testing of all patients with this rare tumor.

Original languageEnglish (US)
Article number21058
Pages (from-to)1753-1759
Number of pages7
JournalAmerican Journal of Cardiology
Volume115
Issue number12
DOIs
StatePublished - Jun 15 2015

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Succinate Dehydrogenase Gene Mutations in Cardiac Paragangliomas'. Together they form a unique fingerprint.

  • Cite this

    Martucci, V. L., Emaminia, A., Del Rivero, J., Lechan, R. M., Magoon, B. T., Galia, A., Fojo, T., Leung, S., Lorusso, R., Jimenez, C., Shulkin, B. L., Audibert, J. L., Adams, K. T., Rosing, D. R., Vaidya, A., Dluhy, R. G., Horvath, K. A., & Pacak, K. (2015). Succinate Dehydrogenase Gene Mutations in Cardiac Paragangliomas. American Journal of Cardiology, 115(12), 1753-1759. [21058]. https://doi.org/10.1016/j.amjcard.2015.03.020